O-glycan profiling of serum glycan for potential renal cancer biomarkers

5Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Serum was obtained from 25 male renal cell carcinoma (RCC) patients and 21 healthy males. O-glycans were released by a β-elimination reaction and purified by graphitized carbon cartridge solid phase extraction, then profiled by matrix-assisted laser desorption/ionisation-time of flight mass spectrometry. After noise removal and peak alignment, 1372 peaks were extracted from 200000 data points. Feature peaks were analyzed by calculation of differential sensitivity and specificity. The combination of two feature peaks was chosen as a biomarker and could clearly differentiate RCC and normal samples in our study group. © 2013 The Author(s).

Cite

CITATION STYLE

APA

Gao, Y., Ma, F., Zhang, W., Zhong, F., Tang, H. L., Xu, D. F., & Zhao, L. (2013). O-glycan profiling of serum glycan for potential renal cancer biomarkers. Science China Life Sciences, 56(8), 739–744. https://doi.org/10.1007/s11427-013-4498-9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free